GlassScriptPhysician profile
Keith A Brown
NPI 1992366371
$12,406.46
in general payments reported to CMS, 2019-2025
37 companies · $2,085 in 2025
The $2,085 reported for 2025 was more than what 94% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $16.56 · 2022: $1,525 · 2023: $4,017 · 2024: $4,763 · 2025: $2,085.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,855 · Grant: $3,364 · Education: $646.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,854.70 |
| Grant | $3,364.00 |
| Education | $645.97 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $4,197.40 | 2023-2025 | Ensite, Gallant, Aveir |
| Atricure, INC. | $2,070.88 | 2023-2025 | Atriclip Laa Exclusion System, Epi-Sense Guided Coagulation System With Visitrax, Synergy Ablation System |
| Boston Scientific Corporation | $905.02 | 2023-2025 | Watchman Flx, General - Therapies, Cds Broad Portfolio Offering |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $797.36 | 2023-2025 | Lifevest |
| E.R. Squibb & Sons, L.L.C. | $672.47 | 2023-2025 | Camzyos, Eliquis |
| Abiomed | $334.49 | 2024-2025 | Impella |
| Amgen INC. | $277.57 | 2023-2025 | Repatha, Repatha |
| Impulse Dynamics (USA) INC. | $181.15 | 2024 | Optimizer |
| Boehringer Ingelheim Pharmaceuticals, INC. | $158.29 | 2023-2025 | Jardiance |
| Novartis Pharmaceuticals Corporation | $117.29 | 2024-2025 | |
| Kestra Medical Technology Services, INC. | $114.47 | 2023-2025 | Assure Wcd |
| Merck Sharp & Dohme LLC | $105.82 | 2023-2025 | Verquvo |
| Astrazeneca Pharmaceuticals LP | $95.92 | 2023-2025 | Farxiga, Wainua |
| Pfizer INC. | $88.71 | 2022-2024 | |
| Medtronic, INC. | $82.57 | 2023 | Azure Xt Dr Mri Surescan |
Show all 37 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| American Regent | $81.29 | 2024 | Injectafer |
| Irhythm Technologies, INC. | $67.48 | 2023-2024 | Zio Xt Patch, Zio Monitor |
| Scpharmaceuticals INC. | $59.62 | 2024 | |
| Janssen Biotech, INC. | $43.48 | 2025 | |
| Janssen Pharmaceuticals, INC | $42.15 | 2023-2024 | Xarelto |
| Kiniksa Pharmaceuticals International, Plc | $36.65 | 2024 | Arcalyst |
| Actelion Pharmaceuticals US, INC. | $34.62 | 2023-2025 | Opsumit, Uptravi |
| Vivus LLC | $32.73 | 2025 | Pancreaze |
| Abbvie INC. | $31.41 | 2025 | |
| Novo Nordisk INC | $31.01 | 2025 | Wegovy |
| Alnylam Pharmaceuticals INC. | $25.09 | 2025 | Onpattro |
| Neurocrine Biosciences, INC. | $24.36 | 2025 | |
| Heartflow, INC. | $22.83 | 2025 | |
| Daiichi Sankyo INC. | $19.89 | 2023 | Injectafer |
| Neurelis, INC. | $19.42 | 2025 | Valtoco |
| Takeda Pharmaceuticals U.S.A., INC. | $18.32 | 2025 | Entyvio |
| Aimmune Therapeutics, INC. | $18.12 | 2025 | Zenpep |
| Regeneron Healthcare Solutions, INC. | $17.41 | 2024 | Evkeeza |
| Ardelyx, INC. | $17.40 | 2025 | Ibsrela |
| Terumo Medical Corporation | $16.33 | 2024 | Glidewire, Progreat, Metacross Otw |
| Sanofi-Aventis U.S. LLC | $15.64 | 2023 | |
| Esperion Therapeutics, INC. | $15.24 | 2024 | Nexletol |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Keith Brown listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.